Nutex Health Q1 net loss $5.1M; revenue falls 29% YoY to $56.3M

Nutex Health Inc.

2023-Q1 EPS reported -$0.01 revenue$56,329,417

Net loss attributable to Nutex Health of $5.1M ($0.01 EPS) vs net income of $21.4M ($0.04 EPS) in Q1 2022.
Net revenue $56.3M, down 29% from $79.1M; hospital division revenue $49.3M vs $79.1M; population health contributed $7.0M.
Adjusted EBITDA $2.4M; cash from operations $1.1M; cash and equivalents $32.8M at March 31.
Closed three unprofitable Texas facilities in Q1; expects to open 4-5 micro hospitals in 2023 and 14 by end 2025.
Entered $100M prepaid advance with Yorkville (received $12.6M net in April); $100M Lincoln Park Capital commitment unused.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Nutex Health Inc. reported first quarter 2023 results: revenue $56.3 million, net income Net loss attributable to Nutex Health of $5.1 million.

Period: first quarter 2023
Revenue: $56.3 million
Net income: Net loss attributable to Nutex Health of $5.1 million
Result: reported results

Exact text from the filing

Financial Highlights for the Three Months Ended March 31, 2023: ● Net revenue of $56.3 million. ● Net loss attributable to Nutex Health of $5.1 million.

View on SEC.gov

Browse all earnings releases →

Nutex Health Inc. filing history →

Source: SEC EDGAR

accession 0001558370-23-009897

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.